Abstract
Herein we report the development of a novel linker platform for tumour-responsive antibody–drug conjugates.
Funding Information
  • Engineering and Physical Sciences Research Council
  • Biotechnology and Biological Sciences Research Council
  • UK Research and Innovation
  • Cystic Fibrosis Trust
  • Cancer Research UK

This publication has 53 references indexed in Scilit: